Combined Therapy of Experimental Autoimmune Uveitis by a Dual-Drug Nanocomposite Formulation with Berberine and Dexamethasone.
Chang HuangZhutian ZhangJifeng GuDan LiShunxiang GaoRong ZhangRong ShiJianguo SunPublished in: International journal of nanomedicine (2023)
BBR@MSN-DEX@Gel serves as a promising dual-drug nanocomposite formulation for future treatment of autoimmune uveitis.
Keyphrases
- juvenile idiopathic arthritis
- drug induced
- ankylosing spondylitis
- reduced graphene oxide
- drug delivery
- multiple sclerosis
- quantum dots
- low dose
- current status
- adverse drug
- high dose
- solid phase extraction
- stem cells
- rheumatoid arthritis
- emergency department
- systemic lupus erythematosus
- wound healing
- aqueous solution
- electronic health record